Marathon charges $89000 a year for new new muscular dystrophy drug – CNBC


CNBC

Marathon charges $89000 a year for new new muscular dystrophy drug
CNBC
A patient with Duchenne muscular dystrophy controls a motorized wheelchair. DMD afflicts about 1 in 3,500 boys worldwide. The U.S. Food and Drug Administration last week approved a drug made by Marathon Pharmaceuticals to treat Duchenne muscular …
Marathon to charge $89000 for DMD drug after 70-fold increasePharmacy Today, American Pharmacists Association, pharmacist.com
This drug just got the FDA's OK — and an $89K price tagTHV11.com
What We're Reading: DMD Drug Gets $89K Price Tag; Necessary Drug Price Hikes; and ACA TaxesAJMC.com Managed Markets Network
Patch.com –Endpoints News –Counsel & Heal –Washington Post
all 96 news articles »

Comments

comments

You must be logged in to post a comment Login